Pharma & Healthcare Market Research Report

Report Filter Reset All

Sort By Price

Published Date

Category

Clear All

Publishers

Clear All

Report Type

Continents

Clear All

Regions

Clear All

Countries

Clear All

Pharma & Healthcare

Global Clevidipine Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Clevidipine (INN, trade name Cleviprex) is a dihydropyridine calcium channel blocker indicated for the reduction of blood pressure when oral therapy is not f...

$3,480.00 06 August, 2019 | GIR (Global Info Research)

Clevidipine (INN, trade name Cleviprex) is a dihydropyridine calcium channel blocker indicated for the reduction of blood pressure when oral therap...

Pharma & Healthcare

Global Colesevelam Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Colesevelam is a bile acid sequestrant administered orally. Colesevelam is used along with diet, weight loss, and exercise to reduce the amount of cholestero...

$3,480.00 06 August, 2019 | GIR (Global Info Research)

Colesevelam is a bile acid sequestrant administered orally. Colesevelam is used along with diet, weight loss, and exercise to reduce the amount of ...

Pharma & Healthcare

Global Ciclesonide Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Ciclesonide is a glucocorticoid used to treat asthma and allergic rhinitis. It is marketed under the brand names Alvesco for asthma and Omnaris, Omniair, and...

$3,480.00 06 August, 2019 | GIR (Global Info Research)

Ciclesonide is a glucocorticoid used to treat asthma and allergic rhinitis. It is marketed under the brand names Alvesco for asthma and Omnaris, Om...

Pharma & Healthcare

Global Rufinamide Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Rufinamide is an anticonvulsant medication. It is used in combination with other medication and therapy to treat Lennox–Gastaut syndrome and various other se...

$3,480.00 06 August, 2019 | GIR (Global Info Research)

Rufinamide is an anticonvulsant medication. It is used in combination with other medication and therapy to treat Lennox–Gastaut syndrome and variou...

Pharma & Healthcare

Global Certolizumab pegol Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Certolizumab pegol (CDP870, tradename Cimzia) is a biologic medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic arthritis and an...

$3,480.00 06 August, 2019 | GIR (Global Info Research)

Certolizumab pegol (CDP870, tradename Cimzia) is a biologic medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic arthri...

Pharma & Healthcare

Global Degarelix Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Degarelix (INN) or degarelix acetate (USAN), sold under the brand name Firmagon among others, is a hormonal therapy used in the treatment of prostate cancer....

$3,480.00 06 August, 2019 | GIR (Global Info Research)

Degarelix (INN) or degarelix acetate (USAN), sold under the brand name Firmagon among others, is a hormonal therapy used in the treatment of prosta...

Pharma & Healthcare

Global Etravirine Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Etravirine (ETR, brand name Intelence, formerly known as TMC125) is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptas...

$3,480.00 06 August, 2019 | GIR (Global Info Research)

Etravirine (ETR, brand name Intelence, formerly known as TMC125) is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse tr...

Pharma & Healthcare

Global Entereg (alvimopan) Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Entereg (alvimopan) is the first and only FDA-approved agent indicated to accelerate the time to gastrointestinal (GI) recovery following surgeries that incl...

$3,480.00 06 August, 2019 | GIR (Global Info Research)

Entereg (alvimopan) is the first and only FDA-approved agent indicated to accelerate the time to gastrointestinal (GI) recovery following surgeries...

Pharma & Healthcare

Global Granisetron Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy and Radiotherapy. Its main eff...

$3,480.00 06 August, 2019 | GIR (Global Info Research)

Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy and Radiotherapy. It...

Pharma & Healthcare

Global Plerixafor Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Plerixafor (INN and USAN, trade name Mozobil) is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients into the bloodstream. Scope...

$3,480.00 06 August, 2019 | GIR (Global Info Research)

Plerixafor (INN and USAN, trade name Mozobil) is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients into the bloodstre...